Notebook

SEEKING SHELTER: Surplus lab chimps need a place to stay. While no plans are under way to build them a golf course or shuffleboard court, a nonprofit organization has been established to create a "retirement home" for chimpanzees not needed in biomedical or behavioral research. Chimp Haven, a San Antonio, Texas-based group, aims to build a facility to provide long-term housing for the unneeded chimps. The United States has a surplus of chimpanzees bred for research purposes, a result of the s

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

SEEKING SHELTER: Surplus lab chimps need a place to stay. While no plans are under way to build them a golf course or shuffleboard court, a nonprofit organization has been established to create a "retirement home" for chimpanzees not needed in biomedical or behavioral research. Chimp Haven, a San Antonio, Texas-based group, aims to build a facility to provide long-term housing for the unneeded chimps. The United States has a surplus of chimpanzees bred for research purposes, a result of the success of a National Institutes of Health-funded breeding program established in the 1980s, the decrease in use of the chimp model for testing of HIV vaccines, and the fact that the animals can live for up to 60 years. Currently, more than 1,500 chimps are housed in U.S. labs, according to Chimp Haven. Linda Brent, a Ph.D. anthropologist who chairs the group's board of directors, notes that its proposed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies